Interestingly, our data demonstrated that DXR-resistant osteosarcoma cells decreased mRNA levels of TFAM gene compared to their sensitive counterpart, thus suggesting that the downregulation of mitochondrial biogenesis could be the process involved in the DXR resistance onset. The gene discussed is TFAM; the disease is osteosarcoma.